Immunopathogenesis of systemic sclerosis

被引:128
作者
White, B [1 ]
机构
[1] VET ADM MED CTR, BALTIMORE, MD 21218 USA
关键词
D O I
10.1016/S0889-857X(05)70296-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated T cells, B cells, and nonspecific inflammatory cells cause tissue damage in patients with systemic sclerosis (SSc). Of these activated cells, the T cells play a central role. Soluble mediators and cellular cytotoxicity are major mechanisms of activating or damaging fibroblasts, endothelial cells, and other vascular cells in SSc. Certain autoantibody targets are specific for SSc, and some targets are homologous to viruses. At this time, however, the contributions of antibodies to tissue damage in SSc patients are less apparent than the contributions of cellular immunity.
引用
收藏
页码:695 / +
页数:1
相关论文
共 81 条
[1]   EXPRESSION AND FUNCTION OF SURFACE-ANTIGENS ON SCLERODERMA FIBROBLASTS [J].
ABRAHAM, D ;
LUPOLI, S ;
MCWHIRTER, A ;
PLATERZYBERK, C ;
PIELA, TH ;
KORN, JH ;
OLSEN, I ;
BLACK, C .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1164-1172
[2]   MOLECULAR CHARACTERIZATION OF AN AUTOANTIGEN OF PM-SCL IN THE POLYMYOSITIS SCLERODERMA OVERLAP SYNDROME - A UNIQUE AND COMPLETE HUMAN CDNA-ENCODING AN APPARENT 75-KD ACIDIC PROTEIN OF THE NUCLEOLAR COMPLEX [J].
ALDERUCCIO, F ;
CHAN, EKL ;
TAN, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :941-952
[3]  
ALMS WJ, 1992, CLIN RES, V40, pA396
[4]  
BERMAN B, 1992, Journal of Dermatological Science, V3, P82, DOI 10.1016/0923-1811(92)90040-I
[5]   INJECTION OF ANTICENTROMERE ANTIBODIES IN INTERPHASE DISRUPTS EVENTS REQUIRED FOR CHROMOSOME MOVEMENT AT MITOSIS [J].
BERNAT, RL ;
BORISY, GG ;
ROTHFIELD, NF ;
EARNSHAW, WC .
JOURNAL OF CELL BIOLOGY, 1990, 111 (04) :1519-1533
[6]   A MOLECULAR AND SEROLOGIC ANALYSIS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AND COMPLEMENT COMPONENT-C4 IN SYSTEMIC-SCLEROSIS [J].
BRIGGS, D ;
STEPHENS, C ;
VAUGHAN, R ;
WELSH, K ;
BLACK, C .
ARTHRITIS AND RHEUMATISM, 1993, 36 (07) :943-957
[7]   INCREASED LEVELS OF ENDOTHELIN-1 IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH SYSTEMIC-SCLEROSIS CONTRIBUTE TO FIBROBLAST MITOGENIC ACTIVITY IN-VITRO [J].
CAMBREY, AD ;
HARRISON, NK ;
DAWES, KE ;
SOUTHCOTT, AM ;
BLACK, CM ;
DUBOIS, RM ;
LAURENT, GJ ;
MCANULTY, RJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (04) :439-445
[8]  
CLEMENTS PJ, 1990, J RHEUMATOL, V17, P908
[9]   IMMUNOHISTOCHEMICAL LOCALIZATION OF TRANSFORMING GROWTH FACTOR-BETA(1) IN THE LUNGS OF PATIENTS WITH SYSTEMIC-SCLEROSIS, CRYPTOGENIC FIBROSING ALVEOLITIS AND OTHER LUNG DISORDERS [J].
CORRIN, B ;
BUTCHER, D ;
MCANULTY, BJ ;
DUBOIS, RM ;
BLACK, CM ;
HARRISON, NK ;
LAURENT, GJ .
HISTOPATHOLOGY, 1994, 24 (02) :145-150
[10]   INTERLEUKIN-8 AND NEUTROPHILS IN SYSTEMIC-SCLEROSIS WITH LUNG INVOLVEMENT [J].
CRESTANI, B ;
SETA, N ;
PALAZZO, E ;
ROLLAND, C ;
VENEMBRE, P ;
DEHOUX, M ;
BOUTTEN, A ;
SOLER, P ;
DOMBRET, MC ;
KAHN, MF ;
AUBIER, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :1363-1367